259 related articles for article (PubMed ID: 11191838)
1. Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors.
Sacchetti G; Bernini M; Gobbi M; Parini S; Pirona L; Mennini T; Samanin R
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):66-72. PubMed ID: 11191838
[TBL] [Abstract][Full Text] [Related]
2. Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.
Parini S; Renoldi G; Battaglia A; Invernizzi RW
Neuropsychopharmacology; 2005 Jun; 30(6):1048-55. PubMed ID: 15668723
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study.
Mateo Y; Fernández-Pastor B; Meana JJ
Br J Pharmacol; 2001 Aug; 133(8):1362-70. PubMed ID: 11498523
[TBL] [Abstract][Full Text] [Related]
4. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.
Sacchetti G; Bernini M; Bianchetti A; Parini S; Invernizzi RW; Samanin R
Br J Pharmacol; 1999 Nov; 128(6):1332-8. PubMed ID: 10578149
[TBL] [Abstract][Full Text] [Related]
5. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
[TBL] [Abstract][Full Text] [Related]
6. The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain.
Alba-Delgado C; Borges G; Sánchez-Blázquez P; Ortega JE; Horrillo I; Mico JA; Meana JJ; Neto F; Berrocoso E
Psychopharmacology (Berl); 2012 May; 221(1):53-65. PubMed ID: 22038538
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.
Invernizzi RW; Parini S; Sacchetti G; Fracasso C; Caccia S; Annoni K; Samanin R
Br J Pharmacol; 2001 Jan; 132(1):183-8. PubMed ID: 11156576
[TBL] [Abstract][Full Text] [Related]
8. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α
Fernández-Pastor B; Ortega JE; Grandoso L; Castro E; Ugedo L; Pazos Á; Meana JJ
Neuropharmacology; 2017 Mar; 114():114-122. PubMed ID: 27908769
[TBL] [Abstract][Full Text] [Related]
9. Pilocarpine treatments differentially affect alpha2-adrenoceptors which modulate the firing rate of locus coeruleus neurones and the synthesis and release of noradrenaline in rat brain.
Garro MA; Pineda J; Giralt MT; Ugedo L
Pharmacol Toxicol; 1999 Aug; 85(2):74-9. PubMed ID: 10488688
[TBL] [Abstract][Full Text] [Related]
10. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
12. Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine.
Mateo Y; Pineda J; Meana JJ
J Neurochem; 1998 Aug; 71(2):790-8. PubMed ID: 9681471
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
Mongeau R; Weiss M; de Montigny C; Blier P
Neuropharmacology; 1998 Jul; 37(7):905-18. PubMed ID: 9776386
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat.
Arrue A; Ruiz-Ortega JA; Ugedo L; Giralt MT
Neurosci Lett; 2003 Feb; 337(3):123-6. PubMed ID: 12536039
[TBL] [Abstract][Full Text] [Related]
15. Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain.
Kawahara Y; Kawahara H; Kaneko F; Tanaka M
Psychopharmacology (Berl); 2007 Sep; 194(1):73-81. PubMed ID: 17534604
[TBL] [Abstract][Full Text] [Related]
16. Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment.
Yoshioka M; Matsumoto M; Numazawa R; Togashi H; Smith CB; Saito H
Eur J Pharmacol; 1995 Dec; 294(2-3):565-70. PubMed ID: 8750719
[TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies.
Dalley JW; Stanford SC
Br J Pharmacol; 1995 Apr; 114(8):1717-23. PubMed ID: 7599940
[TBL] [Abstract][Full Text] [Related]
18. In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus.
Mongeau R; Blier P; de Montigny C
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):266-72. PubMed ID: 8097564
[TBL] [Abstract][Full Text] [Related]
19. Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade.
Linnér L; Arborelius L; Nomikos GG; Bertilsson L; Svensson TH
Biol Psychiatry; 1999 Sep; 46(6):766-74. PubMed ID: 10494444
[TBL] [Abstract][Full Text] [Related]
20. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
